194 related articles for article (PubMed ID: 35508298)
1. miRNAs-mediated overexpression of Periostin is correlated with poor prognosis and immune infiltration in lung squamous cell carcinoma.
Bai X; Chen H; Oliver BG
Aging (Albany NY); 2022 May; 14(9):3757-3781. PubMed ID: 35508298
[TBL] [Abstract][Full Text] [Related]
2. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
4. LIMK2 Is a Novel Prognostic Biomarker and Correlates With Tumor Immune Cell Infiltration in Lung Squamous Cell Carcinoma.
Su Y; Xu B; Shen Q; Lei Z; Zhang W; Hu T
Front Immunol; 2022; 13():788375. PubMed ID: 35273591
[TBL] [Abstract][Full Text] [Related]
5.
Yi C; Zang N; Gao L; Ren F
Aging (Albany NY); 2024 May; 16(11):9498-9517. PubMed ID: 38819947
[TBL] [Abstract][Full Text] [Related]
6. Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma.
Luo P; Jiang Y; Ding S; Jiang S; Tang R; Tang Z
Biomed Res Int; 2022; 2022():4944758. PubMed ID: 35692583
[TBL] [Abstract][Full Text] [Related]
7. Advanced Glycation End Products' Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Yang J; Lin M; Zhang M; Wang Z; Lin H; Yu Y; Zheng Q; Chen X; Wu Y; Yao Q; Li J
Genet Res (Camb); 2023; 2023():7129325. PubMed ID: 37497166
[TBL] [Abstract][Full Text] [Related]
8. LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis.
Wu KL; Tsai YM; Huang YC; Wu YY; Chang CY; Liu YW; Hsu YL; Hung JY
Thorac Cancer; 2023 Feb; 14(4):407-418. PubMed ID: 36516959
[TBL] [Abstract][Full Text] [Related]
9. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
10. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
[TBL] [Abstract][Full Text] [Related]
11. Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma: A study based on bioinformatics analysis.
Wu D; Huo C; Jiang S; Huang Y; Fang X; Liu J; Yang M; Ren J; Xu B; Liu Y
Cancer Med; 2021 Apr; 10(8):2787-2801. PubMed ID: 33314711
[TBL] [Abstract][Full Text] [Related]
12. The expression of POSTN and immune cell infiltration are prognostic factors of lung adenocarcinoma.
Gao F; Liu J; Gan H
Medicine (Baltimore); 2022 Aug; 101(34):e30187. PubMed ID: 36042584
[TBL] [Abstract][Full Text] [Related]
13. Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma.
Liu H; Li T; Dong C; Lyu J
PLoS One; 2022; 17(3):e0264645. PubMed ID: 35290415
[TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
[TBL] [Abstract][Full Text] [Related]
15. [Exploring the Role of PCDHGB4 in the Occurrence of Lung Squamous Cell Carcinoma Based on Bioinformatics Analysis].
Lu R; Abuduhailili X; Li Y; Ning J; Feng Y
Zhongguo Fei Ai Za Zhi; 2024 Mar; 27(3):199-215. PubMed ID: 38590195
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets.
Qi L; Gao C; Feng F; Zhang T; Yao Y; Wang X; Liu C; Li J; Li J; Sun C
J Cell Biochem; 2019 Nov; 120(11):18956-18966. PubMed ID: 31241205
[TBL] [Abstract][Full Text] [Related]
18. SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer.
Hou W; Li GS; Gao L; Lu HP; Zhou HF; Kong JL; Chen G; Xia S; Wei HY
BMC Med Genomics; 2022 May; 15(1):114. PubMed ID: 35581615
[TBL] [Abstract][Full Text] [Related]
19. GADD45B predicts lung squamous cell carcinoma survival and impacts immune infiltration, and T cell exhaustion.
Lv Y; Liu Z; Xiong K; Duan H; Yang J; Liao P
Autoimmunity; 2023 Dec; 56(1):2209706. PubMed ID: 37165780
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
